Quality of Life After Cytoreductive Surgery and Intraperitoneal Chemotherapy

K

Kyungpook National University

Status

Not yet enrolling

Conditions

Colorectal Cancer Metastatic

Treatments

Procedure: Cytoreductive surgery and intraperitoneal chemotherapy

Study type

Observational

Funder types

Other

Identifiers

NCT03503071
KNUHC03

Details and patient eligibility

About

Cytoreductive surgery with intraperitoneal chemotherapy is one of the most important treatments for patients with colorectal cancer and peritoneal metastasis. For the best survival rates, complete removal of all metastatic lesions is the most important part of treatment, and various surgical procedures are required for the complete cytoreduction. Therefore, the postoperative morbidity rates are higher than those of localized colon cancer surgeries and patients can experience a prolonged recovery period and deterioration of physical activities over a long period. The aim of this study is to investigate the change of quality of life after cytoreductive surgery and intraperitoneal chemotherapy for colorectal cancer.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Colorectal cancer peritoneal metastasis
  • Pseudomyxoma peritonei
  • ECOG (Eastern Cooperative Oncology Group) performance status 0-3
  • Normal bone marrow, kidney, and liver function
  • Patient must sign and date the informed consent

Exclusion criteria

  • Palliative surgery
  • Palliative intraperitoneal chemotherapy
  • Psychotic disorder
  • Drug abuser

Trial contacts and locations

1

Loading...

Central trial contact

Soo Yeun Park, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems